tetano
Editor, Senior Moderator
Cureus
. 2022 Sep 10;14(9):e29003.
doi: 10.7759/cureus.29003. eCollection 2022 Sep.
Post-COVID-19 Vaccine Limbic Encephalitis: A Case Report
Khalid Albsheer[SUP] 1 [/SUP], Abdalla Fadul[SUP] 2 [/SUP], ELMustafa Abdalla[SUP] 2 [/SUP], Gihan Mohamed[SUP] 2 [/SUP], Mohamed Elawad[SUP] 3 [/SUP], Abdulaziz Zafar[SUP] 2 [/SUP]
Affiliations
Abstract
Limbic encephalitis (LE) diagnosis can be challenging due to its broad spectrum of clinical presentation and variety of causes. The most commonly known causes include paraneoplastic and autoimmune, but they can also occur post-vaccine. Since 2020, many people worldwide have received the coronavirus disease 2019 (COVID-19) vaccine after FDA approval. Mild self-limited neurological adverse reactions, including headache and dizziness, were reported post-vaccine. However, emerging few neurological severe events, including encephalitis, have also been reported. Herein, we present a case of a middle-aged female who presented with seizures after two days of receiving the second dose of the Moderna COVID-19 vaccine. A diagnosis of limbic encephalitis was made based on head MRI findings. It was treated with immunosuppressive agents and responded well with no additional neurological sequelae. This case is unique as it highlights a possible association between limbic encephalitis and the COVID-19 vaccine.
Keywords: autoimmune limbic encephalitis; covid-19 encephalitis; encephalitis syndrome; limbic; sars-cov-2-associated encephalitis.
. 2022 Sep 10;14(9):e29003.
doi: 10.7759/cureus.29003. eCollection 2022 Sep.
Post-COVID-19 Vaccine Limbic Encephalitis: A Case Report
Khalid Albsheer[SUP] 1 [/SUP], Abdalla Fadul[SUP] 2 [/SUP], ELMustafa Abdalla[SUP] 2 [/SUP], Gihan Mohamed[SUP] 2 [/SUP], Mohamed Elawad[SUP] 3 [/SUP], Abdulaziz Zafar[SUP] 2 [/SUP]
Affiliations
- PMID: 36249609
- PMCID: PMC9550179
- DOI: 10.7759/cureus.29003
Abstract
Limbic encephalitis (LE) diagnosis can be challenging due to its broad spectrum of clinical presentation and variety of causes. The most commonly known causes include paraneoplastic and autoimmune, but they can also occur post-vaccine. Since 2020, many people worldwide have received the coronavirus disease 2019 (COVID-19) vaccine after FDA approval. Mild self-limited neurological adverse reactions, including headache and dizziness, were reported post-vaccine. However, emerging few neurological severe events, including encephalitis, have also been reported. Herein, we present a case of a middle-aged female who presented with seizures after two days of receiving the second dose of the Moderna COVID-19 vaccine. A diagnosis of limbic encephalitis was made based on head MRI findings. It was treated with immunosuppressive agents and responded well with no additional neurological sequelae. This case is unique as it highlights a possible association between limbic encephalitis and the COVID-19 vaccine.
Keywords: autoimmune limbic encephalitis; covid-19 encephalitis; encephalitis syndrome; limbic; sars-cov-2-associated encephalitis.